In this study, five known sesquiterpene lactones (STL) with an α-methylene-γ-lactone motif, including two eudesmanolides, 1β-hydroxyalantolactone (1) and ivangustin (2), and three 1,10-seco-eudesmanolides, 1-O-acetylbritannilactone (3), 1,6-O, O-diacetylbritannilactone (4), and 6α-O(2-methylbutyryl)britannilactone (5) were isolated from the flower heads of the medicinal plant Inula britannica. Their structures were characterized by spectroscopic methods. X-ray data of 2 is reported for the first time. Among them, eudesmanolides 1 and 2 exhibited remarkable cytotoxicity against HEp2, SGC-7901 and HCT116 human cancer cell lines, comparable with etoposide (Vp-16) used as reference drug. Furthermore, treatment of HEp2 cells with 1 induced apoptosis associated with cleaved procaspase-3 and PARP. The biological assays carried out with normal cells (CHO) revealed that all sesquiterpenes were weakly selective against the cancer cell lines tested.
HarveyAL. (2008) Natural products in drug discovery. Drug Discovery Today, 13, 894–901;
2.
NewmanDJ, CraggGM. (2012) Natural products as sources of new drugs over the 30 years from 1981 to 2010. Journal of Natural Products, 75, 311–335;
3.
CraggGM, GrothausPG, NewmanDJ. (2009) Impact of natural products on developing new anti-cancer agents. Chemical Reviews, 109, 3012–3043.
4.
MerfortI. (2011) Perspectives on sesquiterpene lactones in inflammation and cancer. Current Drug Targets, 12, 1560–1573;
5.
GhantousA, Gali-MuhtasibH, VuorelaH, SalibaNA, DarwicheN. (2010) What made sesquiterpene lactones reach cancer clinical trials?Drug Discovery Today, 15, 668–678;
6.
JaneckaA, WyrebskaA, GachK, FichnaJ, JaneckiT. (2012) Natural and synthetic alpha-methylenelactones and alpha-methylenelactams with anticancer potential. Drug Discovery Today, 17, 561–572;
7.
ZhangS, WonY, OngC, ShenH. (2005) Anti-cancer potential of sesquiterpene lactones: Bioactivity and molecular mechanisms. Current Medicinal Chemistry. Anti-cancer Agents, 5, 239–249.
8.
BohlmannF, MahantaPK, JakupovicJ, RastogiRC, NatuAA. (1978) New sesquiterpene lactones from Inula species. Phytochemistry, 17, 1165–1172;
KhanAL, HussainJ, HamayunM, GilaniSA, AhmadS, RehmanG, KimYH, KangSM, LeeIJ. (2010) Secondary metabolites from Inula britannica L. and their biological activities. Molecules, 15, 1562–1577;
ZhaoYM, ZhangML, ShiOW, KiyotaH. (2006) Chemical constituents of plants from the genus Inula. Chemistry & Biodiversity, 3, 371–384;
13.
SecaAML, GrigoreA, PintoDCGA, SilvaAMS. (2014) The genus Inula and their metabolites: From ethnopharmacological to medicinal uses. Journal of Ethnopharmacology, 154, 286–310.
14.
GaoJM, YangSX, QinJC. (2013) Azaphilones: Chemistry and biology. Chemical Reviews, 113, 4755–4811;
15.
LiH, XiaoJ, GaoYQ, TangJJ, ZhangAL, GaoJM. (2014) Chaetoglobosins from Chaetomium globosum, an endophytic fungus in Ginkgo biloba, and their phytotoxic and cytotoxic activities. Journal of Agricultural and Food Chemistry, 62, 3734–3741;
16.
TangJJ, ZhangFY, WangDM, TianJM, DongS, GaoJM. (2013) Semisynthesis and antifeedant activity of new derivatives of a dihydro-beta-agarofuran from Parnassia wightiana. International Journal of Molecular Sciences, 14, 19484–19493;
17.
WangDM, ZhangCC, ZhangQ, ShafiqN, PescitelliG, LiDW, GaoJM. (2014) Wightianines A-E, dihydro-beta-agarofuran sesquiterpenes from Parnassia wightiana, and their antifungal and insecticidal activities. Journal of Agricultural and Food Chemistry, 62, 6669–6676.
18.
QiJ-L, FuY, ShiX-W, WuY-B, WangY-Z, ZhangD-Q, ShiQ-W. (2008) Sesquiterpene lactones and their anti-tumor activity from the flowers of Inula britannica. Letters in Drug Design Discovery, 5, 433–436.
19.
BaiN, LaiC-S, HeK, ZhouZ, ZhangL, QuanZ, ZhuN, ZhengQY, PanM-H, HoC-T. (2006) Sesquiterpene lactones from Inula britannica and their cytotoxic and apoptotic effects on human cancer cell lines. Journal of Natural Products, 69, 531–535.
20.
GongHQ, WuQX, LiuLL, YangJL, WangR, ShiYP. (2011) Sesquiterpenoids from the aerial parts of Inula japonica. Helvetica Chimica Acta, 94, 1269–1276;
21.
ZhuJX, QinJJ, WangHR, ZhuY, ZhangWD, JinHZ. (2011) Monoterpenes and other chemical constituents from the aerial parts of Inula japonica. Chemistry of Natural Compounds, 47, 303–305;
22.
YangC, WangCM, JiaZJ. (2003) Sesquiterpenes and other constituents from the aerial parts of Inula japonica. Planta Medica, 69, 662–666.
23.
ShiXW, QiJL, WuYB, FuY, WangYZ, ZhangDQ. (2008) Simultaneous quantification of six sesquiterpene lactones in Inula britannica L. by RP-LC. Chromatographia, 68, 281–285.
24.
DongS, TangJ-J, ZhangC-C, TianJ-M, GuoJ-T, ZhangQ, LiH, GaoJ-M. (2014) Semisynthesis and in vitro cytotoxic evaluation of new analogues of 1-O-acetylbritannilactone, a sesquiterpene from Inula britannica. European Journal of Medicinal Chemistry, 80, 71–82.
25.
LaemmliUK. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680–685.
AmorimMH, Gil da CostaRM, LopesC, BastosMM. (2013) Sesquiterpene lactones: adverse health effects and toxicity mechanisms. Critical Reviews in Toxicology, 43, 559–579.
28.
HerzW, SumiY, SudarsanamV, RaulaisD. (1967) Constituents of Iva species. IX. Ivangulin, a novel seco-eudesmanolide from Iva angustifolia. The Journal of Organic Chemistry, 32, 3658–3662;
29.
QinJ-J, JinH-Z, ZhuJ-X, FuJ-J, ZengQ, ChengX-R, ZhuY, ShanL, ZhangS-D, PanY-X, ZhangW-D. (2010) New sesquiterpenes from Inula japonica Thunb. with their inhibitory activities against LPS-induced NO production in RAW264.7 macrophages. Tetrahedron, 66, 9379–9388.
30.
DolomanovOV, BourhisLJ, GildeaRJ, HowardJA, PuschmannH. (2009) OLEX2: a complete structure solution, refinement and analysis program. Journal of Applied Crystallography, 42, 339–341.
31.
PalatinusL, ChapuisG. (2007) SUPERFLIP-a computer program for the solution of crystal structures by charge flipping in arbitrary dimensions. Journal of Applied Crystallography, 40, 786–790.
32.
SheldrickGM. (2007) A short history of SHELX. Acta Crystallographica Section A, 64, 112–122.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
